miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors

BLOOD

Sharma, S; Pavlasova, GM; Seda, V; Cerna, KA; Vojackova, E; Filip, D; Ondrisova, L; Sandova, V; Kostalova, L; Zeni, PF; Borsky, M; Oppelt, J; Liskova, K; Kren, L; Janikova, A; Pospisilova, S; Fernandes, SM; Shehata, M; Rassenti, LZ; Jaeger, U; Doubek, M; Davids, MS; Brown, JR; Mayer, J; Kipps, TJ; Mraz, M, 2021: miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. BLOOD 137(18), p. 2481 - 2494, doi: 10.1182/blood.2020005627

Research Groups:

Microenvironment of Immune Cells
Medical Genomics

CEITEC authors:

Václav Šeda, Ph.D.
Laura Ondrišová
Prof. Marek Mráz, Ph.D.